Suppr超能文献

使用二芳基碘鎓盐前体通过亲核取代对芳族放射性溴化的评估。

Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors.

作者信息

Zhou Dong, Kim Sung Hoon, Chu Wenhua, Voller Thomas, Katzenellenbogen John A

机构信息

Department of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.

Department of Chemistry, University of Illinois at Urbana-Champaign, Champaign, IL, USA.

出版信息

J Labelled Comp Radiopharm. 2017 Jul;60(9):450-456. doi: 10.1002/jlcr.3519. Epub 2017 Jun 14.

Abstract

Radiobromine-labeled compounds can be used for positron emission tomography (PET) imaging (ie, Br) and for radiation therapy (ie, Br). However, the commonly used electrophilic substitution reaction using no-carrier-added radiobromide does not always afford the desired product due to the high reactivity of the brominating intermediate. A nucleophilic substitution by bromide, such as radiobromination of iodonium precursors, provides an alternative route for the synthesis of bromo-radiopharmaceuticals. The applicability of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursors was evaluated using iodonium model compounds and [ Br]/[ Br]bromide. Radiobromination was observed under all conditions tested, in up to quantitative yields. A QMA cartridge treatment method and a base-free method have been developed, and no extra base is needed for either methods. The base-free conditions are mild and afford much cleaner reactions. Up to 20% water is tolerated in the reactions without reducing the radiochemical yields. No-carrier-added and carrier-added reactions afforded similar results. 4-Bromobenzaldehyde and 4-bromobenzoate have been radiosynthesized reliably and in good yields. These results indicate that this method is robust and efficient and thus will provide a route for radiobromination of electron-deficient arenes and an alternative route for the synthesis of bromo-radiopharmaceuticals for biological evaluations.

摘要

放射性溴标记的化合物可用于正电子发射断层扫描(PET)成像(即⁸²Br)和放射治疗(即⁷⁷Br)。然而,由于溴化中间体的高反应活性,使用无载体添加的放射性溴化物的常用亲电取代反应并不总是能得到所需产物。通过溴化物进行亲核取代,例如碘鎓前体的放射性溴化,为溴代放射性药物的合成提供了一条替代途径。使用碘鎓模型化合物和⁸²Br/⁷⁷Br溴化物评估了使用二芳基碘鎓盐前体通过亲核取代进行芳族放射性溴化的适用性。在所有测试条件下均观察到放射性溴化,产率高达定量。已开发出QMA柱处理方法和无碱方法,两种方法都不需要额外的碱。无碱条件温和,反应更纯净。反应中可耐受高达20%的水而不降低放射化学产率。无载体添加和有载体添加的反应得到了相似的结果。已可靠地以高收率放射合成了4-溴苯甲醛和4-溴苯甲酸酯。这些结果表明该方法稳健且高效,因此将为缺电子芳烃的放射性溴化提供一条途径,并为用于生物学评估的溴代放射性药物的合成提供一条替代途径。

相似文献

引用本文的文献

3
Recent Progress in Synthetic Applications of Hypervalent Iodine(III) Reagents.高价碘(III)试剂在合成应用中的最新进展
Chem Rev. 2024 Oct 9;124(19):11108-11186. doi: 10.1021/acs.chemrev.4c00303. Epub 2024 Sep 13.
4
Radiochemistry: A Hot Field with Opportunities for Cool Chemistry.放射化学:一个充满机遇的热门领域——“酷化学”的天地 。
ACS Cent Sci. 2023 Nov 14;9(12):2183-2195. doi: 10.1021/acscentsci.3c01050. eCollection 2023 Dec 27.
5
Translating a radiolabeled imaging agent to the clinic.将放射性标记的成像剂转化为临床应用。
Adv Drug Deliv Rev. 2022 Feb;181:114086. doi: 10.1016/j.addr.2021.114086. Epub 2021 Dec 20.
6
Heavy-ion production of Br and Br.重离子产生的 Br 和 Br。
Sci Rep. 2021 Aug 3;11(1):15749. doi: 10.1038/s41598-021-94922-x.

本文引用的文献

3
4
PARP inhibitors: A new era of targeted therapy.聚(ADP-核糖)聚合酶抑制剂:靶向治疗的新时代。
Maturitas. 2015 May;81(1):5-9. doi: 10.1016/j.maturitas.2015.01.015. Epub 2015 Feb 7.
6
Iodonium metathesis reactions.碘鎓复分解反应。
Angew Chem Int Ed Engl. 2014 Sep 1;53(36):9637-9. doi: 10.1002/anie.201405594. Epub 2014 Jul 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验